Transforming Tomorrow, Today
News & Updates from the National Brain Tumor Society
June 2014
Can Army Cadets from West Point Help Pediatric Brain Cancer Treatments Get to Market?

During a mid-March scientific and policy meeting, a group of cadets from the United States Military Academy at West Point - none biology or pre-med majors - stood before a group of leading international pediatric cancer researchers, representatives from major biopharmaceutical companies, and officials from government agencies like the National Cancer Institute, U.S. Food and Drug Administration, and the European Medicines Agency, and told their distinguished audience - many double their age and far more than double their experience in the field - how they could work together to overcome the barriers to pediatric cancer drug development.

The cadets were presenting preliminary findings from their project "Confronting the Impediments to Pediatric Brain Tumor Treatment Development" during the Pediatric Brain Tumor and Cancer Drug Development Working Group, hosted by the National Brain Tumor Society in Washington, D.C.

Now, the cadets have wrapped up their project, and are ready to let the community know about their exciting plan to help move the field of pediatric brain tumor and cancer research forward. Read more about the intriguing conclusions from the cadets' report.

From the Blog
May 14, 2014
Confronting Acquired Resistance in Brain Tumors

The issue of “acquired resistance” has become a much-discussed topic in recent years within the oncology field. This is one of the single biggest challenges in treating brain tumors. Read More

June 4, 2014
From Head to the Hill to #BTVoice: BTAM Recap

This year, National Brain Tumor Society leveraged the focus on BTAM to share research, policy and resources with the community, as well as invite the community to share your own experiences and knowledge in return. The results were overwhelmingly positive. Read More

see all blog posts
Research in the News
Breaking through the Blood-Brain Barrier

Scientists slow brain tumor growth in mice

New Neuro-Oncology Practice Journal, sponsored by National Brain Tumor Society, officially launches

NovoTTF-100A alternating electric fields therapy for recurrent glioblastoma: An analysis of patient registry data

Cellectar Biosciences Announces Receipt of Orphan Designation of I-124-CLR1404 as Diagnostic for the Management of Glioma from U.S. Food and Drug Administration
Upcoming Events
New York Brain Tumor Walk
New York, NY - Saturday, June 21, 2014
Portland Brain Tumor Walk
Portland, OR - Sunday, July 27, 2014
Community Events
Fest in the Forest
Sherwood Forest, MD - Friday, June 13, 2014
Bob Bard 5K
Quarryville, PA - Saturday, June 14, 2014
Tee Up for Tumors
Ebensburg, PA - Friday, July 11, 2014
Event Spotlight
Denver, CO - Saturday, June 7, 2014
View All Events
Connect facebook twitter youtube flickr donate Forward to a Friend
National Brain Tumor Society is fiercely committed to finding better treatments, and ultimately a cure, for people living with a brain tumor today and anyone who will be diagnosed tomorrow. This means effecting change in the system at all levels.
title Was this e-mail forwarded to you?
Subscribe today. Forward to a friend.
55 Chapel Street, Suite 200, Newton, MA 02458
617 924 9997 | Contact us |
Update email preferences or unsubscribe
© National Brain Tumor Society - All Rights Reserved.